{"name":"BeBetter Med Inc","slug":"bebetter-med-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"BEBT-109 Capsule","genericName":"BEBT-109 Capsule","slug":"bebt-109-capsule","indication":"Other","status":"phase_2"},{"name":"BEBT-109 Capsules","genericName":"BEBT-109 Capsules","slug":"bebt-109-capsules","indication":"Other","status":"phase_2"},{"name":"BEBT-209 Placebo capluses","genericName":"BEBT-209 Placebo capluses","slug":"bebt-209-placebo-capluses","indication":"Other","status":"phase_3"},{"name":"BEBT-908 for injection","genericName":"BEBT-908 for injection","slug":"bebt-908-for-injection","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Ifupinostat Hydrochloride for Injection","genericName":"Ifupinostat Hydrochloride for Injection","slug":"ifupinostat-hydrochloride-for-injection","indication":"Hematologic malignancies (phase 3 development)","status":"phase_3"},{"name":"Ifosfamide for Injection","genericName":"Ifosfamide for Injection","slug":"ifosfamide-for-injection","indication":"Germ cell testicular cancer","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"BEBT-209 capsules","genericName":"BEBT-209 capsules","slug":"bebt-209-capsules","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Ifupinostat Hydrochloride for Injection","genericName":"Ifupinostat Hydrochloride for Injection","slug":"ifupinostat-hydrochloride-for-injection","phase":"phase_3","mechanism":"Ifupinostat is a histone deacetylase (HDAC) inhibitor that blocks HDAC enzymes to promote anti-tumor gene expression and immune activation.","indications":["Hematologic malignancies (phase 3 development)","Solid tumors (investigational)"],"catalyst":""},{"name":"BEBT-109 Capsule","genericName":"BEBT-109 Capsule","slug":"bebt-109-capsule","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BEBT-109 Capsules","genericName":"BEBT-109 Capsules","slug":"bebt-109-capsules","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BEBT-209 Placebo capluses","genericName":"BEBT-209 Placebo capluses","slug":"bebt-209-placebo-capluses","phase":"phase_3","mechanism":"This is a placebo formulation with no active pharmacological mechanism.","indications":[],"catalyst":""},{"name":"BEBT-209 capsules","genericName":"BEBT-209 capsules","slug":"bebt-209-capsules","phase":"phase_3","mechanism":"BEBT-209 capsules are a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Cardiovascular disease"],"catalyst":""},{"name":"BEBT-908 for injection","genericName":"BEBT-908 for injection","slug":"bebt-908-for-injection","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ifosfamide for Injection","genericName":"Ifosfamide for Injection","slug":"ifosfamide-for-injection","phase":"phase_3","mechanism":"Ifosfamide is an alkylating agent that cross-links DNA strands, preventing cancer cell replication and inducing cell death.","indications":["Germ cell testicular cancer","Lymphoma","Soft tissue sarcoma","Bone sarcoma","Cervical cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9UcjdoREZTN0c5cjRMVjJHQ2VUMkdCeXNhUVVEbzMzdWlvd0xOTTI4N3lGTkRMaWFqT3J0dTZCWTU1b0RFcDRVZGxWazByMUJvNTJ1SjlWLS1OZDFSOXdLMEFOeWU2dw?oc=5","date":"2026-04-03","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQVlMwNFBtNHNiczhDTE55cUFGc0d6cEpoNHJhM2R6bGpET1lIV1JEQ0p1dzEtNEVXcG1xd3JhMS1UcUpoa1Z3UGZEaGNZU0FJNXFseWUyVG40X0hRM0lQR21XNUJhbjdVZERqNUtjTVBxaTZvNmRUWlFjMWlHME9HN0RNLVNrQmRSb3k4dU16eUJHbUhYdi1UQkE5QlZDTUhBV3JPUnlmMjNiNUNJUzZEdy1kTTBYUFRBcGRybWJYR2xCVWd6LVpySHZpWUVsczJqRU1sSnl3SDR6NkstNHg0?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"PI3K Inhibitor Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"PI3K Inhibitor Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPUjc5LVJ4dnJkdWdPVElCNjY3SnBHWUV1WHI1akpCRE44WnFTN2k0ckFjeG52Y2lhQzN6bjByMXpOU3hHUjBfVkxFSUpjN2xZSXhiaExGR2JoYnJIUWFTSUZZelcxZEFqd0JmNW9uVWtvN1dWV19vcFk3Y3dKQ2JqODR1d0hwRHVPWHFiMTAxX1JDUGc1VWFnLUZWNA?oc=5","date":"2026-03-24","type":"pipeline","source":"openPR.com","summary":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies, - openPR.com","headline":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOTWdzeDQwQks5WEx4R1AzMWpnVHlBajZwZ2tIMFo1cEpFR0haVDZxRXJQWWQxUG0yYmdQQlRPbG1JWWt4TWw0TGVsblRSUUdDN1JPOWtfVlhRajA4Qng2QUpjeVJKZGZOSGdROGR5NlFqcHBPdFB2cUZUbHpNTnZ0WlhZRy1ZSUFmRVQ5YzBBelJSYmxGcEtkRkt4RmtvNk1s?oc=5","date":"2026-02-10","type":"pipeline","source":"BioWorld News","summary":"Heart intervention device-maker Insight lands $143M SSE IPO - BioWorld News","headline":"Heart intervention device-maker Insight lands $143M SSE IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQY0Q1NmhVOGtVdEpSbU5uNWp1U0lBZHpuVTdnbnZtb2RqVl9INVJYWWQ2Wi1zUDh1Yzc0YjM1LXRTWWdmSnp6ZmQzdEREY3pKS2FPamV1QkYzSXRnd0tjN1Z3OGNBd3B0S2dSNW5TZUhmSHBGbERWWlpJMWpsUkpYZC01d0owUFRpTU96WFFONThHOENvMldkOHlzM3kzTTJ1ZGtR?oc=5","date":"2025-07-18","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":4,"phase_2":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}